SHORT-TERM COST-EFFECTIVENESS OF INSULIN DETEMIR VERSUS NPH INSULIN IN INSULIN-NAIVE SUBJECTS WITH TYPE 2 DIABETES IN SWEDEN

被引：1
|
作者：
Ridderstrale, M. [1 ,2 ]
Ericsson, A. [3 ]
Jensen, M. M. [4 ]
机构：
[1] Skane Univ Hosp, Dept Endocrinol, Malmo, Sweden
[2] Univ Lund Hosp, Dept Clin Sci, Malmo, Sweden
[3] Novo Nordisk Scandinavia AB, Malmo, Sweden
[4] Novo Nordisk Scandinavia AB, Copenhagen, Denmark
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.1351
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A480 / A480
页数：1
相关论文
共 50 条
  • [31] The Impact of Diabetes Duration on Safety and Effectiveness of Insulin Analogs in Insulin-Naive People with Type 2 Diabetes
    Home, Philip
    Khattab, Mohammed
    Swaraj, Soji
    Feriz, Karen
    Prusty, Vinay
    Ghannam, Nadia
    [J]. DIABETES, 2014, 63 : A226 - A226
  • [32] The Effectiveness of Basal Plus Compared with Premixed Insulin in Insulin-Naive Type 2 Diabetes Patients
    Raghavan, Arun
    Nanditha, Arun
    Satheesh, Krishnamoorthy
    Snehalatha, Chamukuttan
    Seeli, Abraham Catherin
    Simon, Mary
    Susairaj, Priscilla
    Ramachandran, Ambady
    [J]. DIABETES, 2019, 68
  • [33] Basal insulin peglispro versus insulin glargine in insulin-naive type 2 diabetes: IMAGINE 2 randomized trial
    Davies, M. J.
    Russell-Jones, D.
    Selam, J. -L.
    Bailey, T. S.
    Kerenyi, Z.
    Luo, J.
    Bue-Valleskey, J.
    Ivanyi, T.
    Hartman, M. L.
    Jacobson, J. G.
    Jacober, S. J.
    [J]. DIABETES OBESITY & METABOLISM, 2016, 18 (11): : 1055 - 1064
  • [34] Comment on Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin-naive type 2 diabetes patients:: cost-effectiveness analysis in the UK setting -: Reply
    Valentine, William J.
    Palmer, Andrew J.
    Lammert, Morten
    Nicklasson, Lars
    Foos, Volker
    Roze, Stephane
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (05) : 968 - 969
  • [35] SMART INSULIN THERAPY INITIATION IMPROVES GLUCOSE CONTROL IN INSULIN-NAIVE SUBJECTS WITH TYPE 2 DIABETES
    Bonet, J.
    Visentin, R.
    Vettoretti, M.
    Facchinetti, A.
    Man, C. Dalla
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A85 - A85
  • [36] The relative cost effectiveness of insulin glargine versus NPH insulin in the UK in people with type 1 diabetes
    McEwan, P.
    Poole, C. D.
    Holmes, P.
    Tetlow, A. P.
    Currie, C. J.
    [J]. VALUE IN HEALTH, 2006, 9 (06) : A225 - A226
  • [37] Glucose Turnover After Replacement of Usual Therapy by Insulin in Insulin-naive Type 2 Diabetes Subjects
    Thabit, H.
    Kumareswaran, K.
    Haidar, A.
    Leelarathna, L.
    Caldwell, K.
    Elleri, D.
    Allen, J. M.
    Nodale, M.
    Wilinska, M. E.
    Jackson, N. C.
    Umpleby, A. M.
    Evans, M. L.
    Hovorka, R.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (06): : 2225 - 2232
  • [38] Self-reported impressions of insulin detemir among patients with type 2 diabetes: Insulin-naive vs. prior insulin users
    Kerney, Donna L.
    Paradis, Diana
    Lucrezia, Laurel
    Brunton, Stephen
    [J]. DIABETES, 2007, 56 : A537 - A537
  • [39] A randomized, treat-to-target trial comparing insulin lispro protamine suspension and insulin detemir in insulin-naive patients with Type 2 diabetes
    Fogelfeld, L.
    Dharmalingam, M.
    Robling, K.
    Jones, C.
    Swanson, D.
    Jacober, S.
    [J]. DIABETIC MEDICINE, 2010, 27 (02) : 181 - 188
  • [40] EVALUATING SHORT-TERM COST-EFFECTIVENESS OF LIRAGLUTIDE VERSUS INSULIN GLARGINE IN PATIENTS WITH TYPE-2 DIABETES IN A CHINESE SETTING
    Fan, C. S.
    Zhong, J.
    Sun, F.
    Liu, F.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A162 - A163
12345